[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Xilio Therapeutics Inc (XLO)

Xilio Therapeutics Inc (XLO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Xilio Therapeutics Inc 828 Winter Street Suite 300 Waltham MA 02451 USA

www.xiliotx.com Employees: 76 P: 857-524-2466

Sector:

Medical

Description:

Xilio Therapeutics Inc. is a biotechnology company which focused on harnessing the immune system to achieve deep and durable clinical responses to improve the lives of patients with cancer. The company's product candidate includes XTX101, XTX202, XTX301 and XTX401 which are in clinical stage. Xilio Therapeutics Inc. is based in WALTHAM, Mass.

Key Statistics

Overview:

Market Capitalization, $K 49,777
Enterprise Value, $K -87,753
Shares Outstanding, K 5,983
Float, K 5,447
% Float 91.04%
Short Interest, K 174
Short Float 2.92%
Days to Cover 5.92
Short Volume Ratio 0.39
% of Insider Shareholders 8.96%
% of Institutional Shareholders 54.29%

Financials:

Annual Sales, $ 43,770 K
Annual Net Income, $ -35,040 K
Last Quarter Sales, $ 13,690 K
Last Quarter Net Income, $ 10,360 K
EBIT, $ -41,990 K
EBITDA, $ -40,450 K

Growth:

1-Year Return -17.64%
3-Year Return -80.95%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.85 on 03/23/26
Next Earnings Date 05/14/26 [--]
Earnings Per Share ttm -6.03
EPS Growth vs. Prev Qtr -102.30%
EPS Growth vs. Prev Year 69.65%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-14 on 03/16/26

XLO Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -393.01%
Return-on-Assets % -33.59%
Profit Margin % -80.05%
Debt/Equity 0.00
Price/Sales 1.08
Price/Cash Flow N/A
Price/Book 1.08
Book Value/Share 7.32
Interest Coverage -0.18
60-Month Beta -0.16
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.